I agree that this site is using cookies. You can find further informations here.
X
Hebart, Holger
116  results:
Search for persons X
?
1

PB1938: REAL WORLD EFFECTIVENESS AND SAFETY OF VENETOCLAX I..:

Schwaner, Ingo ; Hebart, Holger ; Christoph, Losem...
HemaSphere.  7 (2023)  S3 - p. e5034942 , 2023
Link: https://doi.org/10.1097/..
 
?
2

P649: SAFETY AND EFFECTIVENESS IN NAIVE CLL PATIENTS TREATE..:

Ingo, Schwaner ; Hebart, Holger ; Losem, Christof...
HemaSphere.  7 (2023)  S3 - p. e284175f , 2023
Link: https://doi.org/10.1097/..
 
?
3

S214: DISEASE-MODIFYING ACTIVITY OF NAVTEMADLIN (NVTM) CORR..:

Vachhani, Pankit ; Perkins, Andrew ; Mascarenhas, John...
HemaSphere.  7 (2023)  S3 - p. e05521ca , 2023
Link: https://doi.org/10.1097/..
 
?
4

Efficacy and Safety of Tirabrutinib and Idelalisib With or ..:

Kutsch, Nadine ; Pallasch, Christian ; Decker, Thomas...
HemaSphere.  6 (2022)  6 - p. e729 , 2022
Link: https://doi.org/10.1097/..
 
?
5

Preinfection laboratory parameters may predict COVID‐19 sev..:

Kiani, Alexander ; Roesch, Romina ; Wendtner, Clemens M....
Cancer Medicine.  10 (2021)  13 - p. 4424-4436 , 2021
Link: https://doi.org/10.1002/..
 
?
6

Kinetics of Renal Function during Induction in Newly Diagno..:

Bachmann, Friederike ; Schreder, Martin ; Engelhardt, Monika...
Cancers.  13 (2021)  6 - p. 1322 , 2021
Link: https://doi.org/10.3390/..
 
?
7

Phase III randomized, double‐blind study of paclitaxel with..:

Lorenzen, Sylvie ; Knorrenschild, Jorge Riera ; Pauligk, Claudia...
International Journal of Cancer.  147 (2020)  9 - p. 2493-2502 , 2020
Link: https://doi.org/10.1002/..
 
?
8

HOVON110/ReBeL Study: Results of the Phase I Part of a Rand..:

Stevens, Wendy B.C. ; Bakunina, Katerina ; Cuijpers, Marloes...
HemaSphere.  4 (2020)  1 - p. , 2020
Link: https://doi.org/10.1097/..
 
?
9

Prospective Observational Cohort Study to Describe the Use ..:

Hebart, Holger ; Kiehl, Michael ; Tomasek, Jiri...
Advances in Therapy.  36 (2019)  3 - p. 670-683 , 2019
Link: https://doi.org/10.1007/..
 
?
10

CNS progression during vinblastine or targeted therapies fo..:

Ruf, Stephanie ; Hebart, Holger ; Hjalgrim, Lisa Lyngsie...
Pediatric Blood & Cancer.  65 (2018)  6 - p. , 2018
Link: https://doi.org/10.1002/..
 
?
11

Tolerability and efficacy of deferasirox in patients with t..:

Nolte, Florian ; Nückel, Holger ; Schmidt, Burkhard...
Journal of Cancer Research and Clinical Oncology.  144 (2018)  8 - p. 1531-1538 , 2018
Link: https://doi.org/10.1007/..
 
?
12

Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first..:

Schimanski, Carl Christoph ; Staib, Frank ; Göhler, Thomas...
Journal of Cancer Research and Clinical Oncology.  143 (2017)  6 - p. 1023-1034 , 2017
Link: https://doi.org/10.1007/..
 
?
13

Phase II study of bortezomib, cyclophosphamide and dexameth..:

Einsele, Hermann ; Engelhardt, Monika ; Tapprich, Christoph...
British Journal of Haematology.  179 (2017)  4 - p. 586-597 , 2017
Link: https://doi.org/10.1111/..
 
?
14

Randomized phase 2 study of otlertuzumab and bendamustineve..:

Robak, Tadeusz ; Hellmann, Andrzej ; Kloczko, Janusz...
British Journal of Haematology.  176 (2016)  4 - p. 618-628 , 2016
Link: https://doi.org/10.1111/..
 
?
15

Response prediction in metastasised colorectal cancer using..:

Kornmann, Marko ; Hebart, Holger ; Danenberg, Kathleen...
European Journal of Cancer.  48 (2012)  10 - p. 1443-1451 , 2012
Link: https://doi.org/10.1016/..
 
1-15